| [1] |
Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(3): 177-193.
|
| [2] |
Kreso A, Dick JE. Evolution of the cancer stem cell model[J]. Cell Stem Cell, 2014, 14(3): 275-291.
|
| [3] |
O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J]. Nature, 2007, 445(7123): 106-110.
|
| [4] |
Kim ST, Sohn I, Do IG, et al. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer[J]. Cancer Genomics & Proteomics, 2014, 11(5): 259.
|
| [5] |
Schneider M, Huber J, Hadaschik B, et al. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker[J]. BMC Cancer, 2012, 12(1):96.
|
| [6] |
Nosrati A, Naghshvar F, Maleki I, et al. Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran[J]. Gastroenterol Hepatol Bed Bench, 2016, 9(2): 132-139.
|
| [7] |
Dou J, Ni Y, He X, et al. Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells[J]. Am J Transl Res, 2016, 8(1): 98-108.
|
| [8] |
Atashpour S, Fouladdel S, Movahhed TK, et al. Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin[J]. Iran J Basic Med Sci, 2015, 18(7): 635-643.
|
| [9] |
Paulis YW, Huijbers EJ, van der Schaft DW, et al. CD44 enhances tumor aggressiveness by promoting tumor cell plasticity[J]. Oncotarget, 2015, 6(23): 19634-19646.
|
| [10] |
Jing F, Kim HJ, Kim CH, et al. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases[J]. Int J Oncol, 2015, 46(4): 1582-1588.
|
| [11] |
Stotz M, Herzog SA, Pichler M, et al. Cancer stem cell gene variants in CD44 predict outcome in stage Ⅱ and stage Ⅲ colon cancer patients[J]. Anticancer Res, 2017, 37(4): 2011-2018.
|
| [12] |
Li XD, Ji M, Wu J, et al. Clinical significance of CD44 variants expression in colorectal cancer[J]. Tumori, 2013, 99(1): 88-92.
|
| [13] |
Katoh S, Goi T, Naruse T, et al. Cancer stem cell marker in circulating tumor cells: expression of CD44 variant exon 9 is strongly correlated to treatment refractoriness, recurrence and prognosis of human colorectal cancer[J]. Anticancer Res, 2015, 35(1): 239-244.
|
| [14] |
Huang YT, Lin YW, Chiu HM, et al. Curcumin induces apoptosis of colorectal cancer stem Cells by coupling with CD44 marker[J]. J Agric Food Chem, 2016, 64(11): 2247-2253.
|
| [15] |
陈小燕，吴应强，朱蓉, 等. 阿司匹林对人结肠癌细胞中肿瘤干细胞标记物CD44表达的影响[J]. 中国医学创新, 2017, 14(1): 1-4.
|
| [16] |
Fujii M, Sato T. Defining the role of Lgr5+, stem cells in colorectal cancer: from basic research to clinical applications[J]. Genome Med, 2017, 9(1): 66.
|
| [17] |
Han Y, Xue X, Jiang M, et al. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2015, 39(2): 267-273.
|
| [18] |
Hirsch D, Ried T. Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates[J]. Ann Transl Med, 2016, 4(24): 508.
|
| [19] |
Lam CS, Cheung AH, Wong SK, et al. Prognostic significance of CD26 in patients with colorectal cancer[J]. PLoS One, 2014, 9(5): e98582.
|
| [20] |
Song J, Zhang J, Wang J, et al. β1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway[J]. Tumor Biol, 2015, 36(3): 2013-2021.
|
| [21] |
Zhu Y, Feng Y, Liu H, et al. CD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis[J]. Int J Clin Exp Pathol, 2015, 8(3): 2627-2637.
|
| [22] |
Lemos C, Hardt MS, Juneja M, et al. MACC1 induces tumor progression in transgenic mice and colorectal cancer patients via increased pluripotency markers Nanog and Oct4[J]. Clin Cancer Res, 2016, 22(11): 2812-2824.
|
| [23] |
Zhou F, Mu YD, Liang J, et al. Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma[J]. Oncol Lett, 2014, 7(2): 507-512.
|
| [24] |
Nangia-Makker P, Yu Y, Farhana L, et al. Colorectal cancer stem cells[M]// Cancer stem cells: emerging concepts and future perspectives in translational incology. Germany: Springer International Publishing, 2015.
|